Tuesday, November 4, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

A Bold Forecast Sets NewtekOne Apart from Market Consensus

Robert Sasse by Robert Sasse
September 17, 2025
in Analysis, Banking & Insurance, Earnings, Turnaround
0
Newtek Business Services Stock
0
SHARES
73
VIEWS
Share on FacebookShare on Twitter

While shares of Newtek Business Services Corp. (NewtekOne) have faced persistent weakness in recent months, a notable analyst projection has emerged that challenges prevailing market sentiment. Investment firm B. Riley has issued a strong buy recommendation, accompanied by a highly optimistic earnings forecast for the 2026 fiscal year that significantly outpaces current consensus estimates. This raises a pivotal question regarding the financial services provider’s capacity to meet these ambitious targets.

B. Riley’s analysis presents a 2026 earnings per share (EPS) estimate of $2.52. This figure stands in stark contrast to the broader market consensus, which currently sits at just $1.93. Should NewtekOne achieve this forecast, it would represent a substantial leap from its own projected 2025 EPS, which is guided to land between $2.10 and $2.50.

This confidence appears to be at least partially rooted in the company’s operational history. NewtekOne has a demonstrated track record of exceeding quarterly expectations. As recently as the end of July, the company reported quarterly results that surpassed estimates, posting an EPS of $0.52 against a forecast of $0.50. This consistent ability to outperform forms a foundational element of the more bullish long-term outlook.

Should investors sell immediately? Or is it worth buying Newtek Business Services?

However, the equity’s technical performance tells a different story. Despite the positive analyst commentary, the stock continues to struggle with a lack of momentum. Over the past twelve months, it has traded within a range of $9.12 to $15.49 and currently resides notably below its key moving averages. This price action suggests that the market has yet to fully price in the potential for a significant earnings acceleration.

The central investment dilemma now rests on whether NewtekOne can translate its historical operational execution into the outsized growth predicted by B. Riley, thereby reversing its current negative technical trajectory.

Ad

Newtek Business Services Stock: Buy or Sell?! New Newtek Business Services Analysis from November 4 delivers the answer:

The latest Newtek Business Services figures speak for themselves: Urgent action needed for Newtek Business Services investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 4.

Newtek Business Services: Buy or sell? Read more here...

Tags: Newtek Business Services
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Booz Allen Hamilton Stock
AI & Quantum Computing

Booz Allen Hamilton: A Tale of Two Businesses as AI Hopes Clash with Civil Sector Woes

November 4, 2025
Trevi Therapeutics Stock
Analysis

Trevi Therapeutics Approaches Critical Financial Update

November 4, 2025
EPR Properties Stock
Analysis

EPR Properties: A Tale of Two Markets as Strong Fundamentals Clash with Technical Weakness

November 4, 2025
Next Post
Vishay Precision Stock

Behind Vishay Precision Group's Meteoric Stock Surge

Banner Stock

All Eyes on Fed as Banner Corporation Awaits Rate Decision

Tencent Holdings (ADR) Stock

Tencent's Dual Catalysts: AI Expansion and Strategic Bond Offering Fuel Rally

Recommended

Plug Power Stock

Plug Power’s Financial Crossroads: Can the Hydrogen Innovator Survive?

2 months ago
Novo Nordisk Stock

Economic Tremors in Denmark as Pharma Giant Faces Headwinds

2 months ago

Caesars Entertainment Shows Improvement in Financial Performance

2 years ago
McDonald's Stock

McDonald’s Launches Aggressive Pricing Strategy to Win Back Budget-Conscious Customers

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Integral Ad Science Nears Takeover Finish Line in $1.9 Billion Deal

Insider Trading Divergence at Iridium as Stock Languishes

Gogo’s 5G Network Launch Approaches Amid Critical Earnings Report

Wolfspeed Shares Plunge as Restructuring Fails to Deliver Growth

Wayfair Shares Maintain Upward Trajectory on Strong Financial Turnaround

Westwater Resources Shares Plunge Amid Technical Breakdown

Trending

Booz Allen Hamilton Stock
AI & Quantum Computing

Booz Allen Hamilton: A Tale of Two Businesses as AI Hopes Clash with Civil Sector Woes

by Felix Baarz
November 4, 2025
0

Booz Allen Hamilton Holding Corporation finds itself navigating a complex and challenging period. The consulting behemoth presents...

Trevi Therapeutics Stock

Trevi Therapeutics Approaches Critical Financial Update

November 4, 2025
EPR Properties Stock

EPR Properties: A Tale of Two Markets as Strong Fundamentals Clash with Technical Weakness

November 4, 2025
Integral Ad Science Holding Llc Stock

Integral Ad Science Nears Takeover Finish Line in $1.9 Billion Deal

November 4, 2025
Iridium Communications Stock

Insider Trading Divergence at Iridium as Stock Languishes

November 4, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Booz Allen Hamilton: A Tale of Two Businesses as AI Hopes Clash with Civil Sector Woes
  • Trevi Therapeutics Approaches Critical Financial Update
  • EPR Properties: A Tale of Two Markets as Strong Fundamentals Clash with Technical Weakness

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com